Effects of telmisartan, irbesartan, valsartan, candesartan, and losartan on cancers in 15 trials enrolling 138 769 individuals The ARB Trialists Collaboration

Authors :: Teo, KK
Sleight, P
Gao, P
Yusuf, S
Connolly, S
Swedberg, K
Pfeffer, MA
Granger, CB
McMurray, JJV
Sjoelie, AK
Massie, BM
Carson, P
Lewis, JB
Wachtell, K
Dahlof, B
Devereux, RB
Kjeldsen, SE
Julius, S
Ibsen, H
Lindholm, LH
Olsen, MH
Okin, PM
Califf, R
Holman, RR
Haffner, SM
Dagenais, G
Probstfield, J
Anderson, C
Diaz, R
Dans, A
Levine, M
Unger, T
Fagard, R
Diener, H-C
Sacco, RL
Zanchetti, A
Cohn, JN
Weber, M
Collaboration, ARBT
Source :: JOURNAL OF HYPERTENSION. 29(4)
Publication Year :: 2011

Tools